Literature DB >> 20040559

Strengthening institutional review board review of highly innovative interventions in clinical trials.

Bernard Lo1, Deborah Grady.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 20040559      PMCID： PMC2892656          DOI： 10.1001/jama.2009.1917

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Clinical trial design issues raised during recombinant DNA advisory committee review of gene transfer protocols.

Authors:  Tiffany Scharschmidt; Bernard Lo
Journal:  Hum Gene Ther       Date:  2006-04       Impact factor: 5.695

2.  TGN1412--a regulator's perspective.

Authors:  Christian K Schneider; Ulrich Kalinke; Johannes Löwer
Journal:  Nat Biotechnol       Date:  2006-05       Impact factor: 54.908

3.  The RAC: double, double, toil, and trouble?

Authors:  Hildegund Ertl
Journal:  Mol Ther       Date:  2009-03       Impact factor: 11.454

4.  Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 x 10(6)/L CD4 cell counts: A randomized controlled trial.

Authors:  J O Kahn; D W Cherng; K Mayer; H Murray; S Lagakos
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

5.  LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.

Authors:  S Hacein-Bey-Abina; C Von Kalle; M Schmidt; M P McCormack; N Wulffraat; P Leboulch; A Lim; C S Osborne; R Pawliuk; E Morillon; R Sorensen; A Forster; P Fraser; J I Cohen; G de Saint Basile; I Alexander; U Wintergerst; T Frebourg; A Aurias; D Stoppa-Lyonnet; S Romana; I Radford-Weiss; F Gross; F Valensi; E Delabesse; E Macintyre; F Sigaux; J Soulier; L E Leiva; M Wissler; C Prinz; T H Rabbitts; F Le Deist; A Fischer; M Cavazzana-Calvo
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

6.  Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient.

Authors:  Ninette Amariglio; Abraham Hirshberg; Bernd W Scheithauer; Yoram Cohen; Ron Loewenthal; Luba Trakhtenbrot; Nurit Paz; Maya Koren-Michowitz; Dalia Waldman; Leonor Leider-Trejo; Amos Toren; Shlomi Constantini; Gideon Rechavi
Journal:  PLoS Med       Date:  2009-02-17       Impact factor: 11.069
  6 in total
  6 in total

Review 1.  Strategies for more rapid translation of cellular therapies for children: a US perspective.

Authors:  Rosa Sanchez; Leslie E Silberstein; Robert W Lindblad; Lisbeth A Welniak; Traci Heath Mondoro; John E Wagner
Journal:  Pediatrics       Date:  2013-07-08       Impact factor: 7.124

Review 2.  Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges.

Authors:  Sumit Ghosh; Alex M Brown; Chris Jenkins; Katie Campbell
Journal:  Appl Biosaf       Date:  2020-03-01

3.  A situation analysis of competences of research ethics committee members regarding review of research protocols with complex and emerging study designs in Uganda.

Authors:  Provia Ainembabazi; Barbara Castelnuovo; Stephen Okoboi; Walter Joseph Arinaitwe; Rosalind Parkes-Ratanshi; Pauline Byakika-Kibwika
Journal:  BMC Med Ethics       Date:  2021-09-26       Impact factor: 2.834

4.  Designing Oversight for Nanomedicine Research in Human Subjects: Systematic Analysis of Exceptional Oversight for Emerging Technologies.

Authors:  Susan M Wolf; Cortney Jones
Journal:  J Nanopart Res       Date:  2011-04       Impact factor: 2.253

5.  Building an ethical foundation for first-in-human nanotrials.

Authors:  Rebecca Dresser
Journal:  J Law Med Ethics       Date:  2012       Impact factor: 1.718

Review 6.  Empowering local research ethics review of antibacterial mass administration research.

Authors:  Nelson K Sewankambo; Paul Kutyabami
Journal:  Infect Dis Poverty       Date:  2022-09-28       Impact factor: 10.485
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.